Skip to content
Home/Companies/Biotech/Inotrem
IN

Inotrem

Biotech·France·Active·7yr hold

Inotrem is a healthcare / biotech company, headquartered in France.

Entry
2019
Hold
7yr
Status
Active
Est. EV
–

Who owns Inotrem?

Inotrem is currently owned by Sofinnova Partners through Sofinnova Capital IX (2018 vintage), since 2019. Across its history, Inotrem has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Sofinnova Partners
Most recent investor
Sofinnova Partners
Sofinnova Capital IX · 2018 · Life Sciences VC
2 ownership periods · full history below

Key facts

HQFrance
SectorHealthcare / Biotech

Ownership history

2 ownership periods

Active
Co-held by Sofinnova Partners and Andera Partners since 2019.
Sofinnova Partners
Sofinnova PartnersActive
2019 · present · Sofinnova Capital IX · 2018 · Life Sciences VC
MOIC
–
Andera Partners
Andera PartnersActive
present · BioDiscovery 4 · 2013 · VC
MOIC
–

More from Sofinnova Capital IX

Other portfolio companies in the same fund.

Asceneuron
Active
BiotechSwitzerland· 2020
CorVent Medical
Active
MedTechUS· 2020
Genespire
Active
BiotechItaly· 2020
Nitrase Therapeutics
Active
BiotechUS· 2020
Noema Pharma
Exited 2022
BiotechSwitzerland· 2020
to
Pi-Cardia
Active
MedTechIsrael· 2020

More PE-backed in Biotech

Comparable biotech deals from other GPs.

InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Data refreshed weekly · Sourced from public filings